Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study

Giancarlo Agnelli; Alexander Gallus; Samuel Goldhaber; Sylvia Haas; Menno Huisman; Russel Hull; Ajay Kakkar; Frank Misselwitz; Sebastian Schellong

Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study

Giancarlo Agnelli, Alexander Gallus, Samuel Goldhaber, Sylvia Haas, Menno Huisman, Russel Hull, Ajay Kakkar, Frank Misselwitz, Sebastian Schellong

Research output: Contribution to journal › Article › peer-review

350 Citations (Scopus)

Original language	English
Pages (from-to)	180-187
Number of pages	8
Journal	Circulation
Volume	116
Issue number	2
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Agnelli, G., Gallus, A., Goldhaber, S., Haas, S., Huisman, M., Hull, R., Kakkar, A., Misselwitz, F., & Schellong, S. (2007). Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study. Circulation, 116(2), 180-187.

@article{10235078d2b644f2804680a4e6bc98ee,

title = "Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study",

author = "Giancarlo Agnelli and Alexander Gallus and Samuel Goldhaber and Sylvia Haas and Menno Huisman and Russel Hull and Ajay Kakkar and Frank Misselwitz and Sebastian Schellong",

year = "2007",

language = "English",

volume = "116",

pages = "180--187",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

Agnelli, G, Gallus, A, Goldhaber, S, Haas, S, Huisman, M, Hull, R, Kakkar, A, Misselwitz, F & Schellong, S 2007, 'Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study', Circulation, vol. 116, no. 2, pp. 180-187.

Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study. / Agnelli, Giancarlo; Gallus, Alexander; Goldhaber, Samuel et al.
In: Circulation, Vol. 116, No. 2, 2007, p. 180-187.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study

AU - Agnelli, Giancarlo

AU - Gallus, Alexander

AU - Goldhaber, Samuel

AU - Haas, Sylvia

AU - Huisman, Menno

AU - Hull, Russel

AU - Kakkar, Ajay

AU - Misselwitz, Frank

AU - Schellong, Sebastian

PY - 2007

Y1 - 2007

M3 - Article

SN - 0009-7322

VL - 116

SP - 180

EP - 187

JO - Circulation

JF - Circulation

IS - 2

ER -